SOURCE: BIOLASE Technology, Inc.

BIOLASE Technology, Inc.

November 29, 2011 09:00 ET

BIOLASE to Present at Upcoming Investment Conferences

IRVINE, CA--(Marketwire - Nov 29, 2011) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, announced today that management is scheduled to make investor presentations at two upcoming investment conferences.

The first conference will be CANACCORD Genuity's 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference on Tuesday, December 6, during which COO and CFO Fred Furry is scheduled to present at 10:00 am Pacific Time. The one-day conference is being held at the St. Regis Hotel in San Francisco.

A live audio webcast of the presentation at the CANACCORD Genuity Conference will be available in the Investors section of the BIOLASE Technology website at

The second conference will be the 4th Annual LD MICRO Conference on Thursday, December 8, during which Chairman and CEO Federico Pignatelli is scheduled to present at 11:30 am Pacific Time. The conference is being held December 7-8, at the Luxe Sunset Bel Air Hotel in Los Angeles.

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the World's leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at, Twitter at, and YouTube at

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact:
    Jill Bertotti
    Allen & Caron